POLE and neoplasm: Despite POLE mutations being considered a good prognostic factor, favouring FST, Veneris et al. [29] analysed a case where recurrence was observed, concluding that POLE-mutated EC has high tumour mutation burden, tumour neoantigen production, and tumour-infiltrating T cells.